NCT05333679View on ClinicalTrials.gov

Urine Tenofovir Point-of-care Test to Identify Patients in Need of ART Adherence Support (UTRA Study)

NAActive, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 2, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Risk Reduction
Interventions
DEVICE

UTRA

Collect urine on intervention participants and screen for presence of TFV.

BEHAVIORAL

UTRA feedback

Feedback will be provided to the participant based on the UTRA results on their adherence with provision of standard adherence counseling.

Trial Locations (1)

7925

Desmond Tutu Health Foundation, University of Cape Town, Cape Town

All Listed Sponsors
collaborator

University of Cape Town

OTHER

collaborator

University of Stellenbosch

OTHER

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

University of California, San Francisco

OTHER